When was Quanterix founded?

Quanterix was founded in 2007 and raised its 1st funding round 1 year after it was founded.

Where is Quanterix located?

Quanterix is headquartered in Cambridge, United States. It is registered at Billerica, Massachusetts.

How many employees does Quanterix have?

As of Jun 30, 2026, the latest employee count at Quanterix is 505.

Is Quanterix a funded company?

Quanterix is a funded company, having raised a total of $99.5M across 15 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 29, 2008.

When was the latest funding round of Quanterix?

Quanterix's latest funding was a $***** Grant (prize money) round on Mar 29, 2022, with participation from 1 investor.

What is the annual revenue of Quanterix?

Annual revenue of Quanterix is between $100M and $500M as on Dec 31, 2025

Where does Quanterix rank among its competitors?

Quanterix ranks 3rd amongst 335 active competitors, of which 41 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was BioLife Solutions, which secured $10.4M in Oct, 2023.

Who are the top competitors of Quanterix?

Quanterix's top competitors include Horizon Discovery, Illumina and BioLife Solutions. Among them, BioLife Solutions secured the most recent funding round in October, 2023.

Quanterix - 2026 Company Profile, Team, Funding, Competitors & Financials

Quanterix is a public company based in Cambridge (United States), founded in 2007. It operates as a Developer of assay kits for ultra-sensitive biomarker detection. Quanterix has raised $99.5M in funding from T. Rowe Price. The company has 335 active competitors, including 41 funded and 57 that have exited. Its top competitors include companies like Horizon Discovery, Illumina and BioLife Solutions.

Company Details

Developer of assay kits for ultra-sensitive biomarker detection. The company’s ultra-sensitive detection solution, Simoa, for the disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease.

Website: www.quanterix.com/
Social
Registered Address: Billerica, Massachusetts

Key Metrics

Founded Year

2007

Location

Cambridge, United States

Stage

Public

Total Funding

$99.5M in 15 rounds

Latest Funding Round

Grant (prize money), Mar 29, 2022, $*****

Investors

T. Rowe Price & 16 more

Ranked

3^rd among 335 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2025

Employee Count

505 as on Jun 30, 2026

Investment & Acquisitions

Akoya Biosciences & 2 more

Similar Companies

Horizon Discovery & 387 more

Exit Details

Public

View Quanterix's full profile

Quanterix is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Quanterix Corporation CIN: 208957988 , United States, Active	Dec 26, 999	-	412 (As on Dec 31, 2024)	-
QUANTERIX CORP CIN: 1503274 , United States, Active	Apr 24, 2007	$100M - $500M (As on Dec 31, 2025)	141 (As on Dec 31, 2023)	-

Quanterix got listed on Dec 07, 2017.

Click here to take a look at Quanterix's IPO in detail

Quanterix has raised a total funding of $99.5M over 15 rounds. Its first funding round was on Jul 29, 2008. Its latest funding round was a Grant (prize money) round on Mar 29, 2022 for $*****. 1 investor participated in its latest round. Quanterix has 17 institutional investors.

Here is the list of recent funding rounds of Quanterix:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 29, 2022	6325680	Grant (prize money)	7546669	7030270	8965927	4298040
Jun 14, 2017	7524593	Series D	3742199	5457366	1001082	2839083
Mar 23, 2016	1636632	Series D	4681284	9022540	2271197	Arch Venture Partners & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of Quanterix's funding rounds and investors

Quanterix's employee count trend

Quanterix has 505 employees as of Jun 26. Here is Quanterix's employee count trend over the years:

Uncover Quanterix's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Quanterix include Horizon Discovery, Illumina and BioLife Solutions. Here is the list of Top 10 competitors of Quanterix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Horizon Discovery 2007, Cambridge (United Kingdom), Acquired	Developer of cell lines with genetic modification using AAV gene-editing platform	$46.3M	MVM, DFJ & 13 others	76/100
2nd	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
3rd	Quanterix 2007, Cambridge (United States), Public	Developer of assay kits for ultra-sensitive biomarker detection	$99.5M	T. Rowe Price, Hercules Capital & 15 others	71/100
4th	BioLife Solutions 1987, Bothell (United States), Public	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
5th	Biocare Medical 1997, Concord (United States), Acquired	Manufacturer of primary antibodies and instruments for immunohistochemistry applications	$85M	Excellere Partners, GHO Capital Partners & 3 others	65/100
6th	LGC 1842, Teddington (United Kingdom), Acquired	Provider of analytical testing, reference materials, and diagnostic and therapeutic products	-	Broad Vision Funds, AlpInvest Partners & 4 others	65/100
7th	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	Guotai Junan Securities, CoStone Capital ... & 13 others	64/100
8th	Mapi Pharma 2008, Ness Ziona (Israel), Series B	Clinical stage pharmaceutical company developing extended release versions of generic drugs.	$60M	Shavit Capital, aMoon & 3 others	62/100
9th	Siemens Healthineers 1847, Forchheim (Germany), Public	Developer of AI-based medical diagnostic products for the healthcare sector	-	Skyviews Life Science, HHS & 1 others	62/100
10th	Souzhou Ribo Life Science 2007, Suzhou (China), Public	Developer of nucleic acid drugs based on RNA interference (RNAi) technology	$201M	Panlin Capital, Legend Capital & 13 others	60/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Quanterix's competitors? Click here to see the top ones

Quanterix has made 1 investment in ImmunArray and acquired Akoya Biosciences and UmanDiagnostics.

Here is the list of these investments and acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 09, 2025	Acquisition	Akoya Biosciences	2015	San Francisco (United States)
Jun 26, 2019	Acquisition	UmanDiagnostics	2006	Umea (Sweden)
Sep 28, 2016	Investments	ImmunArray	2006	Rehovot (Israel)